Business transactions attorney Hemant Gupta helps clients in health care, life sciences, and other industries protect their intellectual property (IP) and technology investments.
Hemant’s practice focuses on a wide range of IP and technology matters, including complex software agreements, technology licensing, artificial intelligence (AI), foreign and domestic patent and trademark prosecution, e-commerce, data security, social media, infringement analysis, commercialization agreements, and enforcement of IP assets. Additionally, he regularly counsels clients on the IP and technology aspects of public and private corporate transactions, including mergers and acquisitions, divestitures, joint ventures, and venture capital financing, and handles IP due diligence reviews.
Clients seek Hemant’s advice on growing and protecting their IP assets in preparation for corporate transactions, including patent strategies, IP holding companies, and corporate structures. Hemant also acts as outside IP counsel to help clients navigate potential infringement issues and capitalize on licensing opportunities. Clients value Hemant’s extensive software and patent and trademark prosecution background, which enables him to thoroughly examine their IP to ensure that it is valid and enforceable and that they can use the technology as they expect.
Hemant has represented a broad spectrum of clients, including emerging companies, research institutions, and Fortune 500 companies, in many technology areas, including biotechnology, consumer products, data analytics, health care, industrial chemicals, the Internet of Things (IoT), medical devices, and software.
Before joining Epstein Becker Green, Hemant was a partner at a national technology law firm. Prior to that, he was head of the IP practice at a national law firm. Earlier in his career, he worked in cancer and molecular biology research at a leading children’s hospital and as a software programmer and system administrator at the University of Pennsylvania.
